Healthpeak Properties, Inc. (DOC)
NYSE: DOC · IEX Real-Time Price · USD
18.22
-0.41 (-2.20%)
Apr 25, 2024, 10:37 AM EDT - Market open
Healthpeak Properties Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for DOC stock have an average target of 18.22, with a low estimate of 14 and a high estimate of 25. The average target predicts no change from the current stock price of 18.22.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for DOC stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 2 | 2 | 2 | 3 |
Buy | 3 | 2 | 2 | 2 | 2 | 2 |
Hold | 6 | 5 | 6 | 6 | 6 | 5 |
Sell | 1 | 1 | 1 | 1 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 9 | 11 | 11 | 10 | 10 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Mizuho | Mizuho | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +20.75% | Apr 22, 2024 |
RBC Capital | RBC Capital | Buy Maintains $21 → $22 | Buy | Maintains | $21 → $22 | +20.75% | Apr 10, 2024 |
B of A Securities | B of A Securities | Sell → Strong Buy Upgrades $18 → $25 | Sell → Strong Buy | Upgrades | $18 → $25 | +37.21% | Apr 1, 2024 |
Wells Fargo | Wells Fargo | Hold Initiates $19 | Hold | Initiates | $19 | +4.28% | Mar 25, 2024 |
RBC Capital | RBC Capital | Buy Initiates $21 | Buy | Initiates | $21 | +15.26% | Mar 8, 2024 |
Financial Forecast
Revenue This Year
2.69B
from 2.18B
Increased by 23.48%
Revenue Next Year
2.53B
from 2.69B
Decreased by -6.24%
EPS This Year
0.40
from 0.56
Decreased by -28.63%
EPS Next Year
0.39
from 0.40
Decreased by -3.13%
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 3.0B | 3.2B | 3.0B | 668.1M | 705.0M |
Avg | 2.5B | 2.9B | 2.8B | 642.6M | 678.2M |
Low | 2.1B | 2.4B | 2.6B | 623.6M | 658.0M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 37.2% | 28.6% | 5.7% | -76.1% | 9.7% |
Avg | 15.8% | 13.6% | -2.4% | -77.0% | 5.5% |
Low | -2.0% | -3.5% | -9.2% | -77.7% | 2.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | 0.49 | 0.83 | 0.70 | 0.39 |
Avg | 0.39 | 0.55 | 0.47 | 0.37 |
Low | 0.18 | 0.24 | 0.25 | 0.36 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|
High | -11.9% | 114.3% | 27.0% | -17.3% |
Avg | -30.9% | 43.0% | -15.2% | -20.4% |
Low | -68.5% | -39.3% | -54.0% | -22.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.